Maravai LifeSciences Holdings, Inc. (MRVI) financial statements and ratios from SEC XBRL: revenue $0.2B (TTM), net margin -70.4%, revenue growth 8.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $185.74M |
| Revenue (TTM) | $0.2B |
| Net Margin | -70.4% |
| Operating Margin (TTM) | -56.1% |
| Net Debt / EBITDA | -0.8 |
| Revenue Growth (YoY) | 8.5% |
| EPS Growth (YoY) | -70.4% |
| FCF Growth (YoY) | -127.6% |
| Price / Book | 3.59 |
| Price / Sales | 6.11 |
| FCF Yield | -2.8% |
| Altman Z-Score | 1.61 (distress) |
| Piotroski F-Score | 1/9 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
MRVI overview · MRVI earnings · MRVI KPIs · MRVI documents · MRVI ownership · MRVI peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.